Martin Slater
Slater joins the company – who recently inked a major drug discovery deal with Redx Pharma – in time for the launch of its professional services division.
Prior to Cresset, he was senior research fellow at BioFocus where he worked with their SoftFocus library brand developing chemogenomic tools.
Rob Scoffin, CEO of Cresset, said: “The rapidly increasing demand for our expertise, demonstrated by our recent major collaboration with Redx Pharma, has led us to establish a dedicated Professional Services division.
“Martin’s unrivalled experience of using our tools on customer projects made him the ideal candidate to help drive this division forward.”